These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32546661)

  • 21. Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway.
    Li S; Cui Y; Li M; Zhang W; Sun X; Xin Z; Li J
    J Invest Surg; 2023 Dec; 36(1):2154578. PubMed ID: 36521840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism.
    Sun H; Xu B; Sheveleva E; Chen QM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):25-32. PubMed ID: 18657281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
    Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
    BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro glucocorticoid studies for predicting response to glucocorticoid therapy in adults with malignant lymphoma.
    Bloomfield CD; Smith KA; Peterson BA; Hildebrandt L; Zaleskas J; Gajl-Peczalska KJ; Frizzera G; Munck A
    Lancet; 1980 May; 1(8175):952-6. PubMed ID: 6103302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.
    Kumari R; Willing LB; Jefferson LS; Simpson IA; Kimball SR
    Biochem Biophys Res Commun; 2011 Sep; 412(4):644-7. PubMed ID: 21856283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper.
    Lim W; Park C; Shim MK; Lee YH; Lee YM; Lee Y
    Br J Pharmacol; 2014 Feb; 171(3):735-45. PubMed ID: 24172143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
    Ide H; Inoue S; Mizushima T; Kashiwagi E; Zheng Y; Miyamoto H
    Mol Carcinog; 2019 Dec; 58(12):2297-2305. PubMed ID: 31535408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid receptors in human leukemias and related diseases.
    Thompson EB; Smith JR; Bourgeois S; Harmon JM
    Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation.
    Xu MC; Shi HM; Wang H; Gao XF
    Mol Med Rep; 2013 Jul; 8(1):147-53. PubMed ID: 23660824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies.
    Moalli PA; Rosen ST
    Leuk Lymphoma; 1994 Nov; 15(5-6):363-74. PubMed ID: 7873993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner.
    Pinno J; Bongartz H; Klepsch O; Wundrack N; Poli V; Schaper F; Dittrich A
    Cell Signal; 2016 Aug; 28(8):907-16. PubMed ID: 27094713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.
    Frost RA; Huber D; Pruznak A; Lang CH
    J Cell Biochem; 2009 Dec; 108(5):1192-202. PubMed ID: 19795384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
    Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
    PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K/Akt/mTOR signaling pathway.
    Ge X; Zhou G
    Am J Transl Res; 2021; 13(6):6330-6341. PubMed ID: 34306372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerobic exercise-mediated changes in the expression of glucocorticoid responsive genes in skeletal muscle differ across the day.
    Dunlap KR; Laskin GR; Waddell DS; Black AJ; Steiner JL; Vied C; Gordon BS
    Mol Cell Endocrinol; 2022 Jun; 550():111652. PubMed ID: 35461977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis.
    Yan H; Frost P; Shi Y; Hoang B; Sharma S; Fisher M; Gera J; Lichtenstein A
    Cancer Res; 2006 Feb; 66(4):2305-13. PubMed ID: 16489035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal regulation of core clock gene expression in skeletal muscle following acute aerobic exercise.
    Saracino PG; Rossetti ML; Steiner JL; Gordon BS
    Biochem Biophys Res Commun; 2019 Jan; 508(3):871-876. PubMed ID: 30538043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.
    Kol S; Ben-Shlomo I; Payne DW; Ando M; Rohan RM; Adashi EY
    Mol Cell Endocrinol; 1998 Feb; 137(2):117-25. PubMed ID: 9605513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress.
    Britto FA; Cortade F; Belloum Y; Blaquière M; Gallot YS; Docquier A; Pagano AF; Jublanc E; Bendridi N; Koechlin-Ramonatxo C; Chabi B; Francaux M; Casas F; Freyssenet D; Rieusset J; Giorgetti-Peraldi S; Carnac G; Ollendorff V; Favier FB
    BMC Biol; 2018 Jun; 16(1):65. PubMed ID: 29895328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.